Riskpilot← Back to searchSign inGet full accessSharp Vision Oy
OYActiveY-tunnus 2992822-4Katrintie 53Medical specialists activities · NACE 8622Est. 2019— employees
Revenue 2024
EUR 228K
+5% vs 2023
EBITDA margin
37.3%
+25% vs 2023
Equity ratio
97.5%
Financial strength
Net profit 2024
EUR 65K
+28% vs 2023
| Revenue | EUR 228K | +5% |
| EBITDA | EUR 85K | +25% |
| Net profit | EUR 65K | +28% |
| Total assets | EUR 274K | +17% |
| Equity | EUR 267K | +18% |
| Employees | — | — |
Legal name
Sharp Vision Oy
Y-tunnus number
2992822-4
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
1. huhtikuuta 2019
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin
Company purpose
Lääketiede, lääkärin vastaanotto, silmätaudit, erityisosaamiseeni kuuluvat akuutit ja krooniset silmävaivat, silmänpainetaudin arviot ja hoidot, kaihiarviot, lasten silmäongelmat sekä silmälasimääräykset.
Osakkeiden ostaminen ja niillä voi käydä kauppaa.
Address
Katrintie 53
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 165 | 247 | 216 | 228 |
| Staff expenses | — | −62 | −66 | −85 | −83 |
| EBITDA | 0 | 65 | 136 | 68 | 85 |
| Depreciation & amort. | — | −6 | −4 | −4 | −3 |
| EBIT | 0 | 59 | 132 | 64 | 82 |
| Net financials | — | −1 | −1 | −1 | −0 |
| Profit before tax | 0 | 58 | 131 | 64 | 82 |
| Tax | −0 | 12 | 27 | 13 | 17 |
| Net profit | 0 | 47 | 104 | 51 | 65 |
| Item | 2019 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 0 | 113 | 227 | 235 | 274 |
| Equity | 0 | 90 | 191 | 227 | 267 |
| Long-term debt | — | 12 | 7 | 5 | 2 |
| Short-term debt | — | 10 | 29 | 3 | 5 |
| Total debt | — | 22 | 36 | 8 | 7 |
EBITDA margin
37.3%
This company
15.8%
Market median
+136% vs market
20192024
Equity ratio
97.5%
This company
38.2%
Market median
+155% vs market
20192024
Return on equity
24.3%
This company
18.4%
Market median
+32% vs market
20192024
Net profit margin
28.5%
This company
8.1%
Market median
+252% vs market
20192024
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20192024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MI Chief Executive Officer | Chief Executive Officer | 2019 |
MS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sharp Vision Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohamed Ibrahim Hassan Geneid | Chief Executive Officer | 0 companies |
| Marwa Shokry Abdelmoneim Beltagy | Deputy Chief Executive Officer | 0 companies |